Preview Mode Links will not work in preview mode

Prostate Cancer: Surviving Together

Yes, prostate cancer sucks, so we need to talk about it.

This show is all about conversations...we talk with prostate cancer survivors, caregivers, medical professionals, lawmakers, patient educators, oncologists, imaging specialists, pharmaceutical representatives, partners, lovers, and friends. Pull up a chair and join the discussion! Presented by the Prostate Network, a Kansas City-based support group helping those engaged in the fight.

www.prostatenetwork.org

Mar 11, 2020

@broadinstitute @DanaFarber research initiative partners directly with patients to accelerate and share discoveries in Metastatic Prostate Cancer. We talk to Dr. Eli Van Allen (@VanAllenLab) about driving precision cancer medicine through clinical computational oncology — so when you say "Count Me In," you're...


Sep 1, 2019

Intimacy is almost always the giant unspoken about elephant in the room when we get a room full of prostate cancer patients together.  Thanks to Dr. Rachel S. Rubin, MD, from Washington, DC, we’re going to safely expose our listeners to more details than they probably even know existed. We talk about ED, injections,...


Sep 1, 2019

After he was diagnosed with life-threatening prostate cancer, Intel’s Bryce Olson sequenced his genome which offered clues to new treatments for his disease. We talk about why it's important, and how to set it up with your doctor using the "battle card." Check out Bryce's web site at sequenceme.org or follow him on...


Jun 23, 2019

John Leifer discusses a variety of topics including PTSD and PSA anxiety in prostate cancer patients, trends and complications within the healthcare world, and his advice that Steve takes to heart and passes on to his newly-diagnosed friends. John is a consultant whose clients range from national health systems...


Jun 23, 2019

Charles and Clare Sweeney talk about how clinical trials can be a valuable resource for prostate cancer patients, but they can be laden with twists and turns. What happens when a trial suddenly ends without warning, or an insurance company decides they won't support a patient's participation?